Difference between revisions of "Template:GHB receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Medgirl131 |
||
| Line 14: | Line 14: | ||
* '''Agonists:''' ''Main site:'' [[1,4-Butanediol|1,4-BD]]<!--Prodrug--> | * '''Agonists:''' ''Main site:'' [[1,4-Butanediol|1,4-BD]]<!--Prodrug--> | ||
* [[3-Hydroxyphenylacetic acid|3-HPA]] | * [[3-Hydroxyphenylacetic acid|3-HPA]] | ||
| − | |||
* [[Aceburic acid]]<!--Prodrug--> | * [[Aceburic acid]]<!--Prodrug--> | ||
* [[1,4-Butanediol diacetate|BDDA (DABD)]]<!--Prodrug--> | * [[1,4-Butanediol diacetate|BDDA (DABD)]]<!--Prodrug--> | ||
| Line 27: | Line 26: | ||
* [[HOCPCA]] | * [[HOCPCA]] | ||
* [[Methyl-4-acetoxybutanoate|MAB]]<!--Prodrug--> | * [[Methyl-4-acetoxybutanoate|MAB]]<!--Prodrug--> | ||
| − | * [[NCS-356]] | + | * [[NCS-356]]<!--γ-(p-chlorobenzyl)-γ-hydroxybutanoic acid--> |
* [[NCS-435]]<!--γ-(p-methoxybenzyl)-γ-hydroxybutyric acid--> | * [[NCS-435]]<!--γ-(p-methoxybenzyl)-γ-hydroxybutyric acid--> | ||
* [[Sodium oxybate]] | * [[Sodium oxybate]] | ||
| Line 45: | Line 44: | ||
* [[3-Methyl-GHB]] | * [[3-Methyl-GHB]] | ||
* [[3-Methyl-THCA]] | * [[3-Methyl-THCA]] | ||
| + | * [[4-Benzyl-GHB]] | ||
* [[4-Hydroxy-4-phenylbutyric acid|4-HPBA]] | * [[4-Hydroxy-4-phenylbutyric acid|4-HPBA]] | ||
* [[4-Methyl-THCA]] | * [[4-Methyl-THCA]] | ||
| Line 98: | Line 98: | ||
* [[Valproic acid]] | * [[Valproic acid]] | ||
| − | | group2 = [[ | + | | group2 = [[Sodium-coupled monocarboxylate transporter|SMCT]]s<!--Across BBB--> |
| list2 = | | list2 = | ||
| + | * [[Benzoic acid]] | ||
| + | * [[β-Hydroxybutyric acid|BHB]] | ||
| + | * [[Butyric acid]] | ||
| + | * [[Fenoprofen]] | ||
| + | * [[Ibuprofen]] | ||
| + | * [[Ketoprofen]] | ||
| + | * [[Mesalazine|Mesalazine (5-ASA)]] | ||
| + | * [[Naproxen]] | ||
| + | * [[Nicotinic acid]] | ||
| + | * [[Probenacid]] | ||
| + | * [[Propionic acid]] | ||
| + | * [[Pyruvic acid]] | ||
| + | * [[Salicyclic acid]] | ||
| + | |||
| + | | group3 = [[Vesicular inhibitory amino acid transporter|VIAAT]] | ||
| + | | list3 = | ||
* [[β-Alanine]] | * [[β-Alanine]] | ||
* [[Bafilomycin A1]] | * [[Bafilomycin A1]] | ||
| Line 130: | Line 146: | ||
* [[Valproic acid]] | * [[Valproic acid]] | ||
| − | | group3 = [[ | + | * ''Enhancers:'' [[Glucuronic acid|<small>D</small>-Glucuronic acid]] |
| + | |||
| + | | group3 = [[Hydroxyacid-oxoacid transhydrogenase|HOT]]<!--GHB transhydrogenase; mitochondrial enzyme--> | ||
| list3 = | | list3 = | ||
| + | * [[Cyanide]] | ||
| + | * [[Phenanthroline]] | ||
| + | |||
| + | | group4 = [[Alcohol dehydrogenase|ADH]] | ||
| + | | list4 = | ||
* [[Cimetidine]] | * [[Cimetidine]] | ||
* [[Ethanol]] | * [[Ethanol]] | ||
| Line 137: | Line 160: | ||
* [[Pyrazole]] | * [[Pyrazole]] | ||
| − | | | + | | group5 = [[Aldehyde dehydrogenase|ALDH]] |
| − | | | + | | list5 = |
* [[Acetaldehyde]] | * [[Acetaldehyde]] | ||
* [[Cimetidine]] | * [[Cimetidine]] | ||
Revision as of 01:37, 22 January 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{GHB receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{GHB receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{GHB receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.